Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Capricor Therapeutics (CAPR) Accumulated Depreciation & Amortization (2018 - 2025)

Capricor Therapeutics (CAPR) has 12 years of Accumulated Depreciation & Amortization data on record, last reported at $4.6 million in Q3 2025.

  • For Q3 2025, Accumulated Depreciation & Amortization rose 43.46% year-over-year to $4.6 million; the TTM value through Sep 2025 reached $4.6 million, up 43.46%, while the annual FY2024 figure was $3.5 million, 56.39% up from the prior year.
  • Accumulated Depreciation & Amortization reached $4.6 million in Q3 2025 per CAPR's latest filing, up from $4.2 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $4.6 million in Q3 2025 and bottomed at $756712.0 in Q4 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $2.1 million, with a median of $1.6 million recorded in 2023.
  • Peak YoY movement for Accumulated Depreciation & Amortization: grew 5.31% in 2021, then soared 86.7% in 2023.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $756712.0 in 2021, then skyrocketed by 56.15% to $1.2 million in 2022, then skyrocketed by 86.7% to $2.2 million in 2023, then soared by 56.39% to $3.5 million in 2024, then soared by 34.72% to $4.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $4.6 million in Q3 2025, $4.2 million in Q2 2025, and $3.7 million in Q1 2025.